Patients with lung cancer have higher breath temperature
the ONA take:
According to new research presented at the European Respiratory Society (ERS) International Congress in Munich, Germany, testing the temperature of breath may be an easy method to diagnose patients with lung cancer. In the study, researchers identified 82 patients to receive a breath temperature test after an x-ray examination suggested a diagnosis of lung cancer.
Researchers measured the patients' breath using an X-Halo device, a thermometer for breath. The X-Halo device confirmed lung cancer in 40 patients and rejected the diagnosis in 42 patients.
The researchers found that the patients with lung cancer had an increased breath temperature compared with those without lung cancer. In addition, the temperature rose with their lung cancer stage and the duration in which a patient had smoked. The researchers were also able to identify the cut-off temperature for which lung cancer could be proven accurately.
Researchers hope that they can refine this test to be used to diagnose patients with lung cancer by measuring their breath temperature. They suggest that the test would be simple, cheap, and noninvasive.
Testing the temperature of breath may be an easy method to diagnose patients with lung cancer.
The temperature of exhaled breath could be used to diagnose lung cancer, according to a new study. The research, presented at the European Respiratory Society (ERS) International Congress in Munich today (8 September 2013), suggests that testing the temperature of breath could be a simple and noninvasive method to either confirm or reject the presence of lung cancer.
Many research teams have been looking at the possibility of using breath tests for a number of cancers. This is the first study looking at breath temperature as a marker in lung cancer.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|